Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 4/2010

01-08-2010 | Original Article

Fumaric aciduria: an overview and the first Brazilian case report

Authors: Gabriella Allegri, Marcia J. Fernandes, Fernanda B. Scalco, Patricia Correia, Ruth E. Simoni, Juan C. Llerena Jr, Maria L. Costa de Oliveira

Published in: Journal of Inherited Metabolic Disease | Issue 4/2010

Login to get access

Abstract

Fumaric aciduria is a rare metabolic disease, with 40 cases reported so far. Fumarase deficiency leads mainly to brain abnormalities, developmental delay, and great accumulation of fumaric acid in urine. This work presents the first case of fumaric aciduria described in Brazil, which presented with some interesting clinical and biochemical findings such as colpocephaly, hepatic alterations, and marked metabolic acidosis since birth. Common findings were ventriculomegaly, hypotonia, and microcephaly. Biochemically, besides the high urinary fumaric acid excretion, atypical elevation of plasma citrulline, tyrosine and methionine levels were also observed. In order to show all features and variants of fumaric aciduria, literature data of 40 patients was reviewed and compared with the case reported here. Findings in all these patients demonstrate that this disorder does not yet have its phenotype completely defined; it is important that more patients be described.
Literature
go back to reference Akiba T, Hiraga K, Tuboi S (1984) Intracellular distribution of fumarase in various animals. J Biochem 26:189–195 Akiba T, Hiraga K, Tuboi S (1984) Intracellular distribution of fumarase in various animals. J Biochem 26:189–195
go back to reference Barnes LB, Bishop SH (1975) Adenylosuccinate lyase from human erythrocytes. Int J Biochem 6:497–503CrossRef Barnes LB, Bishop SH (1975) Adenylosuccinate lyase from human erythrocytes. Int J Biochem 6:497–503CrossRef
go back to reference Bayley JP, Launonen V, Tomlinson IPM (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9:20CrossRefPubMed Bayley JP, Launonen V, Tomlinson IPM (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9:20CrossRefPubMed
go back to reference Bonioli E, Di Stefano A, Peri V et al (1998) Fumarate hydratase deficiency. J Inherit Metab Dis 21:435–436CrossRefPubMed Bonioli E, Di Stefano A, Peri V et al (1998) Fumarate hydratase deficiency. J Inherit Metab Dis 21:435–436CrossRefPubMed
go back to reference Bourgeron T, Chretien D, Poggi-Bach J et al (1994) Mutation of fumarase gene in two sibilings with progressive encephalopathy and fumarase deficiency. J Clin Invest 93:2514–2518CrossRefPubMed Bourgeron T, Chretien D, Poggi-Bach J et al (1994) Mutation of fumarase gene in two sibilings with progressive encephalopathy and fumarase deficiency. J Clin Invest 93:2514–2518CrossRefPubMed
go back to reference Brière JJ, Favier J, El Ghouzzi V, Djouadi F et al (2005) Succinate dehydrogenase deficiency in human. CMLS, Cell Mol Life Sci 62:2317–2324CrossRef Brière JJ, Favier J, El Ghouzzi V, Djouadi F et al (2005) Succinate dehydrogenase deficiency in human. CMLS, Cell Mol Life Sci 62:2317–2324CrossRef
go back to reference Coughlin EM, Christensen E, Kunz PL et al (1998) Molecular Analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab 63:254–262CrossRefPubMed Coughlin EM, Christensen E, Kunz PL et al (1998) Molecular Analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab 63:254–262CrossRefPubMed
go back to reference De Meirleir L, Hansikova H, Zeman J et al (2006) Fumarate hydratase deficiency – a rare cause of developmental delay and seizures. J Inherit Metab Dis 29(suppl 1):106 De Meirleir L, Hansikova H, Zeman J et al (2006) Fumarate hydratase deficiency – a rare cause of developmental delay and seizures. J Inherit Metab Dis 29(suppl 1):106
go back to reference Deschauer M, Gizatullina Z, Schulze A et al (2006) Molecular and biochemical investigations in fumarase deficiency. Mol Genet Metab 88:146–152CrossRefPubMed Deschauer M, Gizatullina Z, Schulze A et al (2006) Molecular and biochemical investigations in fumarase deficiency. Mol Genet Metab 88:146–152CrossRefPubMed
go back to reference Elpeleg ON, Amir N, Christensen E (1992) Variability of clinical presentation in fumarase hydratase deficiency. J Pediatr 121:752–754CrossRefPubMed Elpeleg ON, Amir N, Christensen E (1992) Variability of clinical presentation in fumarase hydratase deficiency. J Pediatr 121:752–754CrossRefPubMed
go back to reference Estevez M, Skarda J, Spencer J, Banaszak L, Weaver TM (2002) X-ray crystallographic and kinetic correlation of a clinically observed human fumarase mutation. Prot Sci 11:1552–1557CrossRef Estevez M, Skarda J, Spencer J, Banaszak L, Weaver TM (2002) X-ray crystallographic and kinetic correlation of a clinically observed human fumarase mutation. Prot Sci 11:1552–1557CrossRef
go back to reference Gellera C, Uziel G, Rimoldi M, Zeviani M, Laverda A, Carrara F, DiDonato S (1990) Fumarase deficiency is an autosomal recessive encephalopathy affecting both mitochondrial and the cytosolic enzymes. Neurology 40:495–499PubMed Gellera C, Uziel G, Rimoldi M, Zeviani M, Laverda A, Carrara F, DiDonato S (1990) Fumarase deficiency is an autosomal recessive encephalopathy affecting both mitochondrial and the cytosolic enzymes. Neurology 40:495–499PubMed
go back to reference Gellera C, Cavandini S, Dethlefs S, et al (1994) Fatal mitochondrial encephalopathy caused by fumarase deficiency: molecular-genetic study, in: Sixth International Inborn Errors of Metabolism Congress, Milan, Italy Gellera C, Cavandini S, Dethlefs S, et al (1994) Fatal mitochondrial encephalopathy caused by fumarase deficiency: molecular-genetic study, in: Sixth International Inborn Errors of Metabolism Congress, Milan, Italy
go back to reference Kerrigan JF, Aleck KA, Tarby TJ, Bird CR, Heidenreich RA (2000) Fumaric aciduria: clinical and imaging features. Ann Neurol 47:583–588CrossRefPubMed Kerrigan JF, Aleck KA, Tarby TJ, Bird CR, Heidenreich RA (2000) Fumaric aciduria: clinical and imaging features. Ann Neurol 47:583–588CrossRefPubMed
go back to reference Kimonis VE, Shih K, Mandell R, Shih V (2000) Clinical, radiological and molecular studies in a girl with fumarase deficiency. J Inherit Metab Dis 23(Suppl 1):112 Kimonis VE, Shih K, Mandell R, Shih V (2000) Clinical, radiological and molecular studies in a girl with fumarase deficiency. J Inherit Metab Dis 23(Suppl 1):112
go back to reference Kyle PM, Kisk NM et al (1997) Olygodramnios and polyhydramnios. In: Fisk NM, Moise KJF Jr (eds) Therapy invasive and transplacental, 1st edn. Cambridge University Press, Cambrigde, pp 203–226 Kyle PM, Kisk NM et al (1997) Olygodramnios and polyhydramnios. In: Fisk NM, Moise KJF Jr (eds) Therapy invasive and transplacental, 1st edn. Cambridge University Press, Cambrigde, pp 203–226
go back to reference Lehtonen R (2006) The role of fumarase (FH) in tumorigenesis. University of Helsinki, Finland, Academic dissertation Lehtonen R (2006) The role of fumarase (FH) in tumorigenesis. University of Helsinki, Finland, Academic dissertation
go back to reference Loeffen J, Smeets R, Voit T, Hoffmann G, Smeitink J (2005) Fumarase deficiency presenting with periventricular cysts. J Inherit Metab Dis 28:799–800CrossRefPubMed Loeffen J, Smeets R, Voit T, Hoffmann G, Smeitink J (2005) Fumarase deficiency presenting with periventricular cysts. J Inherit Metab Dis 28:799–800CrossRefPubMed
go back to reference Manning NJ, Olpin SE, Pollitt RJ, Downing M, Heeley AF, Young ID (2000) Fumarate hydratase deficiency: increased fumaric acid in amniotic fluid of two affected pregnancies. J Inherit Metab Dis 23:757–759CrossRefPubMed Manning NJ, Olpin SE, Pollitt RJ, Downing M, Heeley AF, Young ID (2000) Fumarate hydratase deficiency: increased fumaric acid in amniotic fluid of two affected pregnancies. J Inherit Metab Dis 23:757–759CrossRefPubMed
go back to reference Maradin M, Fumić K, Hansikova H et al (2006) Fumaric aciduria: mild phenotype in a 8 year-old girl with novel mutations. J Inherit Metab Dis 29:683CrossRefPubMed Maradin M, Fumić K, Hansikova H et al (2006) Fumaric aciduria: mild phenotype in a 8 year-old girl with novel mutations. J Inherit Metab Dis 29:683CrossRefPubMed
go back to reference Mitchell G, Grompe M, Lambert M et al (2001) Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Volgestein B (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 1777–1805 Mitchell G, Grompe M, Lambert M et al (2001) Hypertyrosinemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Volgestein B (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 1777–1805
go back to reference Narayanan V, Diven W, Ahdab-Barmada M (1996) Congenital fumarase deficiency presenting with hypotonia and areflexia. J Child Neurol 11:252–255CrossRefPubMed Narayanan V, Diven W, Ahdab-Barmada M (1996) Congenital fumarase deficiency presenting with hypotonia and areflexia. J Child Neurol 11:252–255CrossRefPubMed
go back to reference Peters HL, Kahler SG (2003) Inherited Metabolic diseases with dysmorphic features. In: Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel N (eds) Rudolph’s pediatrics, 21st edn. McGraw-Hill, New York, pp 679–82 Peters HL, Kahler SG (2003) Inherited Metabolic diseases with dysmorphic features. In: Rudolph CD, Rudolph AM, Hostetter MK, Lister G, Siegel N (eds) Rudolph’s pediatrics, 21st edn. McGraw-Hill, New York, pp 679–82
go back to reference Phillips TM, Gibson JB, Ellison DA (2006) Fumarate hydratase deficiency in monozygotic twins. Pediatr Neurol 35:150–153CrossRefPubMed Phillips TM, Gibson JB, Ellison DA (2006) Fumarate hydratase deficiency in monozygotic twins. Pediatr Neurol 35:150–153CrossRefPubMed
go back to reference Pollard PJ, Brière JJ, Alam NA et al (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14:2231–2239CrossRefPubMed Pollard PJ, Brière JJ, Alam NA et al (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1a in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14:2231–2239CrossRefPubMed
go back to reference Remes AM, Rantala H, Hiltunen JK, Leisti J, Ruokonen A (1992) Fumarase deficiency: two siblings with enlarged cerebral ventricles and polyhydramnios in utero. Pediatrics 89:730–734PubMed Remes AM, Rantala H, Hiltunen JK, Leisti J, Ruokonen A (1992) Fumarase deficiency: two siblings with enlarged cerebral ventricles and polyhydramnios in utero. Pediatrics 89:730–734PubMed
go back to reference Remes AM, Filppula SA, Rantala H et al (2004) A novel mutation of the fumarase gene in a family with autossomal recessive fumarase deficiency. J Mol Med 82:550–554CrossRefPubMed Remes AM, Filppula SA, Rantala H et al (2004) A novel mutation of the fumarase gene in a family with autossomal recessive fumarase deficiency. J Mol Med 82:550–554CrossRefPubMed
go back to reference Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn errors of metabolic disease: an introduction. J Inherit Metab Dis 29:261–274CrossRefPubMed Saudubray JM, Sedel F, Walter JH (2006) Clinical approach to treatable inborn errors of metabolic disease: an introduction. J Inherit Metab Dis 29:261–274CrossRefPubMed
go back to reference Stone TW, Roberts LA, Morris BJ, Jones PA, Duley JA, Ogilvy HV (1997) Are succinylpurines neurotoxic? Clin Biochem 30:283–284CrossRef Stone TW, Roberts LA, Morris BJ, Jones PA, Duley JA, Ogilvy HV (1997) Are succinylpurines neurotoxic? Clin Biochem 30:283–284CrossRef
go back to reference Tanaka K, West-Dull A, Hine DG, Lynn TB, Lowe T (1980) Gas-Chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clin Chem 26:1847–1853PubMed Tanaka K, West-Dull A, Hine DG, Lynn TB, Lowe T (1980) Gas-Chromatographic method of analysis for urinary organic acids. II. Description of the procedure, and its application to diagnosis of patients with organic acidurias. Clin Chem 26:1847–1853PubMed
go back to reference Taroni F, Gellera C, DiDonato S (1988) Evidence for two distinct mitochondrial malic enzymes in human skeletal muscle: purification and properties of the NAD(P) + dependent enzyme. Biochim Biophys Acta 916:446–454 Taroni F, Gellera C, DiDonato S (1988) Evidence for two distinct mitochondrial malic enzymes in human skeletal muscle: purification and properties of the NAD(P) + dependent enzyme. Biochim Biophys Acta 916:446–454
go back to reference Toth EA, Yeates T (2000) The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway. Structure 8:163–174CrossRefPubMed Toth EA, Yeates T (2000) The structure of adenylosuccinate lyase, an enzyme with dual activity in the de novo purine biosynthetic pathway. Structure 8:163–174CrossRefPubMed
go back to reference Tsai M, Koo J, Yip P, Colman RF, Segall ML, Howell PL (2007) Substrate and product complexes of Escherichia coli adenylosuccinate lyase provide news insight into enzymatic mechanism. J Mol Biol 370:541–554CrossRefPubMed Tsai M, Koo J, Yip P, Colman RF, Segall ML, Howell PL (2007) Substrate and product complexes of Escherichia coli adenylosuccinate lyase provide news insight into enzymatic mechanism. J Mol Biol 370:541–554CrossRefPubMed
go back to reference Walker V, Mills GA, Hall MA, Millward-Sadler GH, English NR, Chalmers RA (1989) A fourth case of fumarase deficiency. J Inherit Metab Dis 12:331–332CrossRefPubMed Walker V, Mills GA, Hall MA, Millward-Sadler GH, English NR, Chalmers RA (1989) A fourth case of fumarase deficiency. J Inherit Metab Dis 12:331–332CrossRefPubMed
go back to reference Whelan DT, Hill RE, McClorry S (1983) Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta 132:309–315CrossRef Whelan DT, Hill RE, McClorry S (1983) Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta 132:309–315CrossRef
go back to reference Zeman J, Krijt J, Statilová L et al (2000) Abnormalities in succinylpurines in fumarase deficiency: possible role in pathogenesis of CNS impairment. J Inherit Metab Dis 23:371–374CrossRefPubMed Zeman J, Krijt J, Statilová L et al (2000) Abnormalities in succinylpurines in fumarase deficiency: possible role in pathogenesis of CNS impairment. J Inherit Metab Dis 23:371–374CrossRefPubMed
go back to reference Zeng WQ, Gao H, Brueton L et al (2006) Fumarase deficiency caused by homozygous P131R mutation and paternal partial isodisomy of chromosome 1. Am J Med Genet A 140A:1004–1009CrossRef Zeng WQ, Gao H, Brueton L et al (2006) Fumarase deficiency caused by homozygous P131R mutation and paternal partial isodisomy of chromosome 1. Am J Med Genet A 140A:1004–1009CrossRef
go back to reference Zinn AB, Kerr DS, Hoppel CL (1986) Fumarase deficiency: a new cause of mitochondrial encephalomyopathy. N Engl J Med 315:469–475PubMed Zinn AB, Kerr DS, Hoppel CL (1986) Fumarase deficiency: a new cause of mitochondrial encephalomyopathy. N Engl J Med 315:469–475PubMed
Metadata
Title
Fumaric aciduria: an overview and the first Brazilian case report
Authors
Gabriella Allegri
Marcia J. Fernandes
Fernanda B. Scalco
Patricia Correia
Ruth E. Simoni
Juan C. Llerena Jr
Maria L. Costa de Oliveira
Publication date
01-08-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 4/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9134-2

Other articles of this Issue 4/2010

Journal of Inherited Metabolic Disease 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.